Related references
Note: Only part of the references are listed.Neutrophil plasticity in the tumor microenvironment
Morgan A. Giese et al.
BLOOD (2019)
EZH2 Inhibition in Ewing Sarcoma Upregulates GD2 Expression for Targeting with Gene-Modified T Cells
Sareetha Kailayangiri et al.
MOLECULAR THERAPY (2019)
Management of recurrent or refractory Ewing sarcoma: A systematic review of phase II clinical trials in the last 15 years
Jie Xu et al.
ONCOLOGY LETTERS (2019)
Programmed cell death ligand 1 (PD-L1) expression is not a predominant feature in Ewing sarcomas
Christian Spurny et al.
PEDIATRIC BLOOD & CANCER (2018)
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
Tathiane M. Malta et al.
CELL (2018)
Partners in crime: neutrophils and monocytes/macrophages in inflammation and disease
Kathryn Prame Kumar et al.
CELL AND TISSUE RESEARCH (2018)
The landscape of genomic alterations across childhood cancers
Susanne N. Groebner et al.
NATURE (2018)
Immunohistochemical analysis and prognostic significance of PD-L1, PD-1, and CD8+tumor-infiltrating lymphocytes in Ewing's sarcoma family of tumors (ESFT)
Isidro Machado et al.
VIRCHOWS ARCHIV (2018)
T cell infiltration into Ewing sarcomas is associated with local expression of immune-inhibitory HLA-G
Christian Spurny et al.
Oncotarget (2018)
Ewing sarcoma
Thomas G. P. Gruenewald et al.
NATURE REVIEWS DISEASE PRIMERS (2018)
High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-EWING99 and Ewing-2008
Jeremy Whelan et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Pan-cancer genome and transcriptome analyses of 1,699 paediatric leukaemias and solid tumours
Xiaotu Ma et al.
NATURE (2018)
Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study
Yongfu Xiong et al.
CANCER MEDICINE (2018)
Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer
S. Chouaib et al.
ONCOGENE (2017)
Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al.
FRONTIERS IN IMMUNOLOGY (2017)
Reprogramming of Tumor-Associated Macrophages with Anticancer Therapies: Radiotherapy versus Chemo- and immunotherapies
Geraldine Genard et al.
FRONTIERS IN IMMUNOLOGY (2017)
Progress in tumor-associated macrophage (TAM)-targeted therapeutics
Chayanon Ngambenjawong et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
Jaehong Kim et al.
MEDIATORS OF INFLAMMATION (2016)
Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas
Semra Paydas et al.
MEDICAL ONCOLOGY (2016)
Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis
Anna-Maria Georgoudaki et al.
CELL REPORTS (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
Dendritic and mast cell involvement in the inflammatory response to primary malignant bone tumours
Y. Inagaki et al.
CLINICAL SARCOMA RESEARCH (2016)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Drug-induced regeneration in adult mice
Yong Zhang et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth
Michal Hameiri-Grossman et al.
ONCOTARGET (2015)
Immunostimulation by OX40 ligand transgenic Ewing sarcoma cells
Dajana Reuter et al.
FRONTIERS IN ONCOLOGY (2015)
Gene expression profiling of Ewing sarcoma tumours reveals the prognostic importance of tumour-stromal interactions: a report from the Children's Oncology Group
Samuel L. Volchenboum et al.
JOURNAL OF PATHOLOGY CLINICAL RESEARCH (2015)
A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Ivraym B. Barsoum et al.
CANCER RESEARCH (2014)
Gene expression profiling of peripheral blood cells: new insights into Ewing sarcoma biology and clinical applications
Joanna Przybyl et al.
MEDICAL ONCOLOGY (2014)
Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
Franck Tirode et al.
CANCER DISCOVERY (2014)
Targeting the DNA Repair Pathway in Ewing Sarcoma
Elizabeth Stewart et al.
CELL REPORTS (2014)
OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Brendan D. Curti et al.
CANCER RESEARCH (2013)
A proposed role for neutrophil extracellular traps in cancer immunoediting
Sivan Berger-Achituv et al.
FRONTIERS IN IMMUNOLOGY (2013)
Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
Richard B. Womer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Macrophage Migration Inhibitory Factor Promotes Tumor Growth and Metastasis by Inducing Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Kendra D. Simpson et al.
JOURNAL OF IMMUNOLOGY (2012)
Common variants near TARDBP and EGR2 are associated with susceptibility to Ewing sarcoma
Sophie Postel-Vinay et al.
NATURE GENETICS (2012)
Cutoff Finder: A Comprehensive and Straightforward Web Application Enabling Rapid Biomarker Cutoff Optimization
Jan Budczies et al.
PLOS ONE (2012)
Macrophage Infiltration Predicts a Poor Prognosis for Human Ewing Sarcoma
Toshifumi Fujiwara et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A simple method for identifying bone marrow mesenchymal stromal cells with a high immunosuppressive potential
Roberta Rizzo et al.
CYTOTHERAPY (2011)
Treatment Outcome of Korean Patients with Localized Ewing Sarcoma Family of Tumors: A Single Institution Experience
Jun Ah Lee et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2011)
R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor 1 Receptor, in Patients With Recurrent or Refractory Ewing Sarcoma Family of Tumors: Results of a Phase II Sarcoma Alliance for Research Through Collaboration Study
Alberto S. Pappo et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8+ T-lymphocyte infiltration and affect tumour progression
Dagmar Berghuis et al.
JOURNAL OF PATHOLOGY (2011)
Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor
Helen J. Knowles et al.
BMC CANCER (2010)
Hypoxia Modulates EWS-FLI1 Transcriptional Signature and Enhances the Malignant Properties of Ewing's Sarcoma Cells In vitro
Dave N. T. Aryee et al.
CANCER RESEARCH (2010)
Different Tumor Microenvironments Contain Functionally Distinct Subsets of Macrophages Derived from Ly6C(high) Monocytes
Kiavash Movahedi et al.
CANCER RESEARCH (2010)
Identification of Cancer Stem Cells in Ewing's Sarcoma
Mario-Luca Suva et al.
CANCER RESEARCH (2009)
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2
Stefan Burdach et al.
CELL CYCLE (2009)
EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation
Guenther H. S. Richter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Polycomb silencers control cell fate, development and cancer
Anke Sparmann et al.
NATURE REVIEWS CANCER (2006)
Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia
DWJ van der Schaft et al.
CANCER RESEARCH (2005)
DNA microarrays reveal relationship of Ewing family tumors to both endothelial and fetal neural crest-derived cells and define novel targets
MS Staege et al.
CANCER RESEARCH (2004)
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
RA Irizarry et al.
BIOSTATISTICS (2003)
Share Paper
